Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Fluvoxamine manufacturer?What's the starting lipitor dose with warfarin?Can lipitor lower pain medication usage?What are the benefits of Pemigatinib?Does Allopurinol cause a gout flare-up initially?
See the DrugPatentWatch profile for vascepa
Vascepa Side Effects: What to Watch For Vascepa, also known as icosapent ethyl, is a prescription omega-3 fatty acid medication used to lower triglycerides in adults with severe hypertriglyceridemia. Like all medications, it comes with potential side effects. Common Side Effects: According to the Vascepa label [1], common side effects, which affect more than 10% of patients, include: 1. Nausea: Approximately 20% of patients in clinical trials reported nausea. 2. Diarrhea: Close to 13% of patients experienced diarrhea. 3. Vomiting: Vomiting was reported by about 10% of patients. 4. Abdominal Pain: Approximately 8% of patients experienced abdominal pain. Serious Side Effects: While relatively rare, there are more serious side effects to be aware of: 1. Pancreatitis: A small number of patients may experience pancreatitis, an inflammation of the pancreas. [2] 2. Increased Bleeding Risk: Vascepa may increase the risk of bleeding, especially in patients with a history of bleeding disorders or taking anticoagulant medications. [1] 3. Psychiatric Events: Rare cases of depression, anxiety, and other psychiatric events have been reported in patients taking Vascepa. [1] What to Do If You Experience Side Effects: If you experience any side effects while taking Vascepa, it's essential to discuss them with your doctor or healthcare provider. They can help you manage the side effects and determine the best course of action. Monitoring and Precautions: It's crucial to follow your doctor's instructions carefully and attend regular check-ups to monitor your triglyceride levels and potential side effects. Sources: [1] - Vascepa (icosapent ethyl) Prescribing Information. American Heart Association. [2] - ClinicalTrials.gov: A Study to Evaluate the Effectiveness and Safety of Vascepa in Patients With Severe Hypertriglyceridemia.
Other Questions About Vascepa :